Le Lézard
Classified in: Health, Business
Subject: RLE

IRA Capital Completes Sale of Medical Office and Life Science Portfolio to Nuveen for $620.4 Million

IRVINE, Calif., Aug. 9, 2021 /PRNewswire/ -- IRA Capital ("IRA"), a Southern-California based private equity firm and one of the largest private buyers of healthcare real estate in the United States, has completed the sale of a medical office and life science portfolio to Nuveen Real Estate for $620.4 Million.

The portfolio totals over 1,165,173 square feet consisting of 29 properties across 13 states which include Arizona, California, Florida, Illinois, Michigan, North Carolina, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, and Wisconsin. The medical office properties are comprised of ambulatory surgery centers, micro-hospitals, freestanding emergency departments, and single and multi-tenant medical office buildings leased to some of the largest health systems in the country.  The life science assets have a primary focus on pharmaceutical testing and medical device manufacturing. The portfolio features strong investment-grade tenancy and long term leases with strong annual escalations. 

"IRA, at its core, is a relationship-focused real estate partner," said Samir Patel, a principal and co-founder of IRA Capital. "We believe in creating value by developing and maintaining long-term partnerships with our tenants, and by helping them become more efficient rather than only focusing on the physical aspects of their property. This partnership approach vs. a traditional Landlord/Tenant relationship has positioned us exceptionally well to continue our growth well into the future."

In early 2020, IRA sold an 18-property medical office portfolio to Welltower REIT and has continued building upon its medical office portfolio throughout COVID, with a primary focus on shifting its strategy towards health-system transactions. IRA acquired approximately $500 Million of transactions in 2020 and intends to deploy approximately $1 Billion in the next year with a primary focus in the healthcare sector, as well as other asset classes such as multifamily, industrial, net lease, and hospitality. 

About IRA Capital

IRA Capital is a Southern-California based private equity firm founded in 2010 that invests capital for its own account and on behalf of its co-investment partners, which include pension funds, institutions, and family offices. IRA primarily invests in commercial real estate assets throughout the United States, with a focus on the medical/healthcare real estate sector. Headquartered in Irvine California, IRA has acquired over six million square feet of property across 30 states, valued in excess of $2.5 Billion. For additional information, please visit: www.iraCapital.com

Press Contact:

Kyle Zimmerman, [email protected], 949.204.5386


These press releases may also interest you

at 07:05
Advent Technologies Holdings, Inc. ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, today announced consolidated financial results for the three months ended June 30, 2022. All amounts are in...

at 07:05
Bentley Systems, Incorporated ("Bentley Systems" or the "Company"), the infrastructure engineering software company, today announced operating results for its second quarter and six months ended June 30, 2022. Second Quarter 2022 Financial Results...

at 07:05
Bragg Gaming Group ("Bragg" or the "Company"), a global B2B gaming technology and content provider, today reported record financial results for the second quarter ended June 30, 2022. The Company also provided an update on its strategic growth...

at 07:05
EVgo Inc. ("EVgo" or the "Company") today announced results for the second quarter of 2022. The Company continues to execute on its growth plans on the back of continued electric vehicle ("EV") adoption and market development. Revenue increased to...

at 07:05
KE Holdings Inc. ("Beike" or the "Company") , a leading integrated online and offline platform for housing transactions and services, today announced that it will report its unaudited financial results for the second quarter of 2022 before the U.S....

at 07:05
ADC Therapeutics SA today reported financial results for the second quarter ended June 30, 2022 and provided business updates. "The ZYNLONTA® launch is advancing steadily as we continue to increase awareness and advocacy. There is significant...

News published on 9 august 2021 at 18:13 and distributed by: